Physician

Atul Kumar Jain, M.D.

According to 2025 Medicare claims, Atul Jain, M.D. (NPI: 1194905711) practices ophthalmology in the San Diego-Chula Vista-Carlsbad, CA market, with the plurality of this provider's patient population coming from San Diego, CA. This provider's primary affiliated billing organization is RETINA CONSULTANTS SAN DIEGO INC (NPI: 1790736098; TIN: 953511595) and primary practice location at 92008-9998.

Jain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 808 traditional Medicare patients, billed 114,527 HCPCS/CPT codes, and received $3,855,802 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 460 prescription claims across 135 beneficiaries totaling $76,261 in drug costs, led by Mounjaro (Tirzepatide). Open Payments data shows 9 records totaling $356. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,426,013 to $3,855,802. Similarly, Part D prescription costs have moved sharply higher in recent years, from $36,372 to $76,261. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.9M2015 Medicare payment: $1,426,013 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,229,169 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,273,361 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $957,387 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,525,936 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,362,454 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,149,835 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,029,336 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,576,437 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,855,802 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157306,434$1,426,013
20166636,536$1,229,169
20176086,669$1,273,361
20185694,952$957,387
20195657,540$1,525,936
202072410,485$2,362,454
202184413,889$3,149,835
202282017,190$3,029,336
202380088,817$3,576,437
2024808114,527$3,855,802

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$49K$99K2015 Drug cost: $36,372 (USD; Tot_Drug_Cst)2016 Drug cost: $30,113 (USD; Tot_Drug_Cst)2017 Drug cost: $34,013 (USD; Tot_Drug_Cst)2018 Drug cost: $21,977 (USD; Tot_Drug_Cst)2019 Drug cost: $29,028 (USD; Tot_Drug_Cst)2020 Drug cost: $45,646 (USD; Tot_Drug_Cst)2021 Drug cost: $50,016 (USD; Tot_Drug_Cst)2022 Drug cost: $38,516 (USD; Tot_Drug_Cst)2023 Drug cost: $98,661 (USD; Tot_Drug_Cst)2024 Drug cost: $76,261 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015137389$36,372
2016123352$30,113
2017120362$34,013
201876197$21,977
201985230$29,028
2020124362$45,646
2021132425$50,016
2022121394$38,516
2023130432$98,661
2024135460$76,261

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2901,753$109
92014Established patient complete exam of visual system511888$102
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more2871,144$74
92134Imaging of retina7982,887$35
92202Extended exam of the back part of the eye with optic nerve drawing448790$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MounjaroTirzepatide411,204$42,416
RestasisCyclosporine14900$9,683
IlevroNepafenac16902$7,166
Prednisolone AcetatePrednisolone Acetate412,010$1,985
LatanoprostLatanoprost1297,253$1,527

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$356Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Atul Kumar Jain, M.D.?

Tedicare shows public-source Medicare data for Atul Kumar Jain, M.D. (NPI 1194905711), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Atul Kumar Jain, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Atul Kumar Jain, M.D.?

Atul Kumar Jain, M.D. is linked to RETINA CONSULTANTS SAN DIEGO INC (billing NPI 1790736098) in the available physician profile data.

Does Atul Kumar Jain, M.D. have Open Payments data?

Atul Kumar Jain, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.